Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $210.86 | 13 | 100.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| ABBVIE INC. | $44.27 | 3 | $0 (2024) |
| Lilly USA, LLC | $31.99 | 2 | $0 (2022) |
| Biohaven Pharmaceuticals, Inc. | $26.34 | 1 | $0 (2021) |
| E.R. Squibb & Sons, L.L.C. | $21.21 | 1 | $0 (2022) |
| GlaxoSmithKline, LLC. | $16.82 | 1 | $0 (2023) |
| Abbott Laboratories | $16.11 | 1 | $0 (2022) |
| Novo Nordisk Inc | $14.32 | 1 | $0 (2022) |
| Astellas Pharma US Inc | $14.09 | 1 | $0 (2022) |
| EISAI INC. | $13.56 | 1 | $0 (2022) |
| PFIZER INC. | $12.15 | 1 | $0 (2022) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $17.23 | 1 | ABBVIE INC. ($17.23) |
| 2023 | $16.82 | 1 | GlaxoSmithKline, LLC. ($16.82) |
| 2022 | $150.47 | 10 | Lilly USA, LLC ($31.99) |
| 2021 | $26.34 | 1 | Biohaven Pharmaceuticals, Inc. ($26.34) |
All Payment Transactions
13 individual payment records from CMS Open Payments
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 03/26/2024 | ABBVIE INC. | UBRELVY (Drug) | Food and Beverage | In-kind items and services | $17.23 | General |
| Category: NEUROSCIENCE | ||||||
| 12/01/2023 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $16.82 | General |
| Category: RESPIRATORY | ||||||
| 10/25/2022 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $13.76 | General |
| Category: NEUROSCIENCE | ||||||
| 10/11/2022 | Novo Nordisk Inc | Rybelsus (Drug), Ozempic | Food and Beverage | In-kind items and services | $14.32 | General |
| Category: Diabetes | ||||||
| 10/06/2022 | Lilly USA, LLC | EMGALITY (Drug), JARDIANCE | Food and Beverage | In-kind items and services | $17.62 | General |
| Category: Neuroscience | ||||||
| 09/16/2022 | Abbott Laboratories | FREESTYLE LIBRE 2 (Device) | Food and Beverage | In-kind items and services | $16.11 | General |
| Category: Diabetes Care | ||||||
| 09/12/2022 | Lilly USA, LLC | MOUNJARO (Drug) | Food and Beverage | In-kind items and services | $14.37 | General |
| Category: Diabetes | ||||||
| 08/30/2022 | E.R. Squibb & Sons, L.L.C. | ELIQUIS (Drug) | Food and Beverage | Cash or cash equivalent | $21.21 | General |
| Category: Cardiovascular | ||||||
| 08/22/2022 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $13.28 | General |
| Category: NEUROSCIENCE | ||||||
| 06/10/2022 | PFIZER INC. | ELIQUIS (Drug) | Food and Beverage | In-kind items and services | $12.15 | General |
| Category: CARDIOVASCULAR;METABOLIC DISEASE | ||||||
| 02/23/2022 | EISAI INC. | Aduhelm (Drug) | Food and Beverage | Cash or cash equivalent | $13.56 | General |
| Category: Neurology | ||||||
| 01/27/2022 | Astellas Pharma US Inc | Myrbetriq (Drug) | Food and Beverage | In-kind items and services | $14.09 | General |
| Category: Urology | ||||||
| 12/03/2021 | Biohaven Pharmaceuticals, Inc. | NURTEC ODT (Drug) | Food and Beverage | In-kind items and services | $26.34 | General |
| Category: PRIMARY CARE | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 9 | 359 | 597 | $77,578 | $28,479 |
| 2022 | 10 | 396 | 645 | $85,804 | $29,896 |
| 2021 | 11 | 435 | 748 | $91,273 | $32,974 |
| 2020 | 10 | 440 | 715 | $89,627 | $27,256 |
All Medicare Procedures & Services
40 procedure records from CMS Medicare Utilization — Page 1 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 100 | 197 | $40,779 | $13,025 | 31.9% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 72 | 153 | $20,808 | $7,361 | 35.4% |
| 90694 | Influenza vaccine, quadrivalent inactivated, 0.5 ml dosage | Office | 2023 | 48 | 48 | $4,833 | $3,487 | 72.1% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2023 | 14 | 14 | $2,996 | $1,480 | 49.4% |
| G0008 | Administration of influenza virus vaccine | Office | 2023 | 49 | 49 | $1,948 | $1,439 | 73.9% |
| 83036 | Hemoglobin a1c level | Office | 2023 | 30 | 79 | $3,397 | $744.20 | 21.9% |
| 87428 | Detection test by immunoassay technique for severe acute respiratory syndrome coronavirus and influenza | Office | 2023 | 18 | 23 | $1,817 | $716.68 | 39.4% |
| G0444 | Annual depression screening, 5 to 15 minutes | Office | 2023 | 12 | 12 | $384.00 | $178.56 | 46.5% |
| 81003 | Automated urinalysis test | Office | 2023 | 16 | 22 | $616.00 | $48.40 | 7.9% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 109 | 223 | $45,269 | $14,355 | 31.7% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 93 | 164 | $21,812 | $6,329 | 29.0% |
| 90694 | Influenza vaccine, quadrivalent inactivated, 0.5 ml dosage | Office | 2022 | 44 | 44 | $2,904 | $2,783 | 95.8% |
| 99496 | Transitional care management services for problem of high complexity | Office | 2022 | 12 | 14 | $5,614 | $2,537 | 45.2% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2022 | 13 | 13 | $2,730 | $1,387 | 50.8% |
| G0008 | Administration of influenza virus vaccine | Office | 2022 | 37 | 37 | $1,443 | $1,035 | 71.7% |
| 83036 | Hemoglobin a1c level | Office | 2022 | 36 | 88 | $3,696 | $820.32 | 22.2% |
| 87428 | Detection test by immunoassay technique for severe acute respiratory syndrome coronavirus and influenza | Office | 2022 | 12 | 12 | $930.00 | $365.39 | 39.3% |
| G0444 | Annual depression screening, 15 minutes | Office | 2022 | 14 | 14 | $434.00 | $206.98 | 47.7% |
| 81003 | Automated urinalysis test | Office | 2022 | 26 | 36 | $972.00 | $78.16 | 8.0% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 106 | 196 | $39,396 | $12,493 | 31.7% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Office | 2021 | 93 | 200 | $26,400 | $9,711 | 36.8% |
| 99496 | Transitional care management services, highly complexity, requiring face-to-face visits within 7 days of discharge | Office | 2021 | 21 | 22 | $8,734 | $3,812 | 43.6% |
| 90694 | Influenza virus vaccine, quadrivalent (aiiv4), inactivated, adjuvanted, preservative free, for injection into muscle, 0.5 ml dosage | Office | 2021 | 47 | 47 | $3,071 | $3,001 | 97.7% |
| 83036 | Hemoglobin a1c level | Office | 2021 | 47 | 128 | $5,376 | $1,225 | 22.8% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2021 | 11 | 11 | $2,288 | $1,203 | 52.6% |
About Lisa Ebert, CNP
Lisa Ebert, CNP is a Family healthcare provider based in Fremont, Ohio. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 12/18/2006. The National Provider Identifier (NPI) number assigned to this provider is 1588727135.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Lisa Ebert, CNP has received a total of $210.86 in payments from pharmaceutical and medical device companies, with $17.23 received in 2024. These payments were reported across 13 transactions from 10 companies. The most common payment nature is "Food and Beverage" ($210.86).
As a Medicare-enrolled provider, Ebert has provided services to 1,630 Medicare beneficiaries, totaling 2,705 services with total Medicare billing of $118,605. Data is available for 4 years (2020–2023), covering 40 distinct procedure/service records.
Practice Information
- Specialty Family
- Location Fremont, OH
- Active Since 12/18/2006
- Last Updated 06/06/2018
- Taxonomy Code 363LF0000X
- Entity Type Individual
- Practice Solo Practitioner
- NPI Number 1588727135
Products in Payments
- ELIQUIS (Drug) $33.36
- VRAYLAR (Drug) $27.04
- NURTEC ODT (Drug) $26.34
- EMGALITY (Drug) $17.62
- UBRELVY (Drug) $17.23
- TRELEGY ELLIPTA (Drug) $16.82
- FREESTYLE LIBRE 2 (Device) $16.11
- MOUNJARO (Drug) $14.37
- Rybelsus (Drug) $14.32
- Myrbetriq (Drug) $14.09
- Aduhelm (Drug) $13.56
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Family Doctors in Fremont
Olivia Martinez, Fp-C, FP-C
Family — Payments: $8,300
Eunsun Kim
Family — Payments: $5,160
Ms. Luann Wolf, Cnp, CNP
Family — Payments: $3,407
Kulbinder Hans, Fnp, FNP
Family — Payments: $2,725
Kip Soviak, Fnp, FNP
Family — Payments: $2,598
Mrs. Amy Arends, Np-C, NP-C
Family — Payments: $2,050